Regulatory

Latest News

Patent Law. | Image Credit: WrightStudio - stock.adobe.com .jpeg
Clearing the Thicket: New Report Outlines Legislative Fixes to Boost Biosimilar Access

July 29th 2025

Patent thickets hinder biosimilar access, driving up costs and delaying affordable treatments. Discover legislative solutions to enhance competition and patient care.

global health and regulatory agencies and biosimilars | Image credit: C Malambo:peopleimages.com - stock.adobe.com
New Approvals Expand Access to Biosimilars for Ophthalmology, Bone, and Joint Conditions

July 28th 2025

insulin biosimilar subcutaneous injection | Image credit: Syda Productions - stock.adobe.com
FDA Approves Kirsty as First Interchangeable Insulin Aspart Biosimilar

July 15th 2025

child in need of psoraisis biosimilar | Image credit: WESTOCK - stock.adobe.com
FDA Approves Steqeyma for Children With Plaque Psoriasis, Psoriatic Arthritis

June 17th 2025

Video Interviews
Podcasts
CFB podcast banner
CFB podcast banner
CFB podcast banner
CFB podcast banner
CfB Podcast Banner
"SEEING EYE TO EYE:  Exploring Different Perspectives on Ophthalmology Biosimilars SEEING EYE TO EYE:  Exploring Different Perspectives on Ophthalmology Biosimilars" with the CfB logo and an image of an eye
CfB podcast banner
CfB podcast banner
podcast banner
image of adalimumab biosmilar eveloped by alvotech prefilled syring

More News

© 2025 MJH Life Sciences

All rights reserved.